KMT2A and leukemia: Critically, PSMB8 was responsible for the self-renewal capacity of leukemia stem cells and the initiation of MLL-rearranged leukemia by regulating the DNA binding with brain abundant membrane attached signal protein 1 (BASP1), positioning it as a promising target for anti-leukemia therapy [47].